World AIDS Day 2025: Honoring Progress, Accelerating Innovation, and Standing Together
On World AIDS Day 2025, Fluorobiotech joins the global community in remembering the lives lost to HIV/AIDS, honoring the resilience of those living with HIV,
Fluorobiotech Achieves ISO 13485 Certification
Fluorobiotech is proud to announce that we have officially been awarded ISO 13485 certification, a major achievement in our ongoing mission to enable high-quality, scalable
Celebrating a Historic Milestone: South Africa Launches Clinical Trials for Its First Locally Developed Cholera Vaccine
This week, Fluorobiotech’s COO, Ross Rayne Vermeulen, attended a landmark event in Johannesburg celebrating the launch of clinical trials for South Africa’s first domestically developed
Fluorobiotech Engages Key Stakeholders at Africa Tech Festival to Advance Biotechnology Innovation Across the Continent
Last week, Fluorobiotech representatives Ross Rayne Vermeulen and Marthinus Janse van Vuuren attended the Africa Tech Festival, one of the continent’s leading gatherings for innovators,
Fluorobiotech Hosts Medicines Patent Pool Representatives for Strategic Discussions on Advancing Africa’s mRNA and Enzyme Manufacturing Capabilities
Last week, Fluorobiotech had the pleasure of welcoming representatives from the Medicines Patent Pool (MPP), Dr. Monica Moschioni (PhD, MPH) and Umut Demirtas to our
mRNA Vaccination Shows Promise in Enhancing Cancer Immunotherapy: New Insights for the Future of Immune-Modulating Technologies
A landmark study presented at the 2025 European Society for Medical Oncology (ESMO) Congress by The University of Texas MD Anderson Cancer Center has provided